Now valued at $11 billion, the latest funding round will help fuel its push into preventative health
Oura has announced that it has closed a Series E funding round of over $900 million, rocketing the smart ring leader’s valuation to $11 billion.
The news is a huge vote of confidence from investors, providing Oura with a massive war chest to accelerate its growth and innovation.
The fundraising caps off a big few weeks for the Finnish company. It comes hot on the heels of the news that it has now sold over 5.5 million smart rings, with shipments having doubled in the last year or so alone.
The company has also unveiled its new Gen 4 Ceramic collection and launched Health Panels, a new blood-testing service that integrates lab results directly into the Oura app, marking its latest major push into preventative health.
According to CEO Tom Hale, this new injection will enable Oura to double down on its strategy, expanding its global reach and furthering its evolution from a simple sleep tracker into a comprehensive health platform.
With its main rivals—Ultrahuman and Ringconn—also currently facing a US import ban, and Samsung remaining quiet on a second-generation Galaxy Ring, this new investment gives Oura the resources to pull even further ahead and solidify its position as the undisputed leader in the smart ring market. How its rivals will respond remains to be seen.
